Urinary aetiocholanolone levels have been measured in 417 women aged between 20 and 70 years. The women were drawn from South East Scotland and South Wales and consisted of patients with either benign or malignant disease of the breast and control patients suffering from no detectable breast disorder. The pattern of aetiocholanolone excretion with respect to age and menopausal status has been defined in each group of patients. No significant differences in urinary levels have been detected between patients with breast disease, whether benign or malignant, and control patients. More detailed examination of the 201 women with early cancer of the breast has also shown that there is no consistent correlation between pre-operative aetiocholanolone levels and factors of prognostic significance detectable at the time of primary treatment-tumour size, grade, round cell infiltration, histological involvement of nodes by tumour and the clinical palpability of lymph nodes.
Summary.-Urinary aetiocholanolone levels have been measured in 417 women aged between 20 and 70 years. The women were drawn from South East Scotland and South Wales and consisted of patients with either benign or malignant disease of the breast and control patients suffering from no detectable breast disorder. The pattern of aetiocholanolone excretion with respect to age and menopausal status has been defined in each group of patients. No significant differences in urinary levels have been detected between patients with breast disease, whether benign or malignant, and control patients. More detailed examination of the 201 women with early cancer of the breast has also shown that there is no consistent correlation between pre-operative aetiocholanolone levels and factors of prognostic significance detectable at the time of primary treatment-tumour size, grade, round cell infiltration, histological involvement of nodes by tumour and the clinical palpability of lymph nodes.
It would seem, therefore, that the prognostic value of pre-operative aetiocholanolone measurements is somewhat limited in patients with early breast cancer. It is noted, however, that low levels of aetiocholanolone are associated with postmenopausal patients, a group in which the prognosis is generally poorer than that in pre-menopausal women. CONSIDERABLE interest in the relation-matched controls (Bulbrook, Hayward ship of urinary androgen metabolites with and Spicer, 1971) . breast cancer has been provoked by the Whilst it is now accepted that low studies of Bulbrook and his colleagues aetiocholanolone levels are associated with (Bulbrook et at., 1962) . These workers a proportion of patients with advanced have indicated that (a) some women with breast cancer who have a poor prognosis advanced cancer have subnormal levels (Kumaoka et al., 1968; Cameron et al., of urinary aetiocholanolone and are un-1970) , the situation in patients with likely to respond to major endocrine early disease remains equivocal, several ablation (Atkins et al., 1968a, b) ; (b) a studies indicating that aetiocholanolone proportion of women with early breast levels are normal in these women (Alquist, cancer also have abnormally low aetio-Jackson and Stewart, 1968; Wade et cholanolone levels (Bulbrook et al., 1962 (Bulbrook et al., ) al., 1969 Cameron et al., 1970) . With and that this is associated with poor the recent finding that C19 androgenic prognosis (Hayward and Bulbrook, 1968) ; steroids may act as precursors for tumour (c) " normal " women who subsequently growth promoting hormones (Miller and develop breast cancer have lower mean Forrest, 1974) , it is even more important excretion of aetiocholanolone than to resolve this conflict.
In an effort to do so, we have retro-Cancer patients.-There were 60 patients spectively examined the results of urinary from Cardiff and 141 patients from Edinburgh aetiocholanolone measurements performed with invasive carcinoma of the breast. All in two major centres in normal women of these cases were deemed to have operable and in patients with either early cancer or early cancer of the breast and the majority or bengndisasofthbras.-Thsewere of international olinical Stages I and II.
Or benign dislese of the breast. These A few cases were in international clinical have been analysed with regard to age Stage III, solely on account of a primary and menopausal status, in order to define tumour of a size greater than 5 cm diameter. the normal pattern of excretion in patients Menstrual status.-Each of the groups and controls, and then related to other has been further divided according to their factors of known prognostic significance. menstrual status, by the following criteria:
Pre-menopausal-patients with regular menstrual periods;
PATIENTS AND METHODS
Menopausal-patients whose periods were Urine was obtained from 417 hospital diminishing in frequency or whose last in-patients in Cardiff and Edinburgh. Pa-period was within 2 years of primary tients were excluded from the study if they treatment;
had known endocrine disease, had been
Post-menopausalpatients whose last receiving steroid preparations of any type period had occurred more than 2 years . 
nias, duodenal ulcers and varicose veins.
These patients were therefore subjected to round cell infiltration was also carried out, These patients were therefore subjected to adsrbdb hmin alc n similar pre-operative stress as subjects with a X breast disorders. Prescott (1972) .
Benign breaest disease.-The 163 women in Tumour size.-The clinical size of the Benign breast disease. 16 woe in tumour was measured by 2 independent tigroupd by enigion dioses No te brtea observers at the time of presentation. The proved by exiso bipy No frthe tumour was measured in 2 planes at righthistological classification of the 76 women from Cardiff was made but the pathological angles and the larger diameter was recorded records were checked to ensure that the in cm. diagnosis of benign disease was correct.
Lymph node involvement.-The clinical
Sufficient numbers of pre-menopausal status of the axillary nodes was assessed women from Edinburgh with benign breast by 2 observers before operation. Microdisease were studied to subdivide this group scopical examination for the presence of further.
tumour was carried out in all cases from which lymph nodes had been removed.
Group 1-fibrocystic disease of the breast In Cardiff, where the standard operations (17 patients) (those patients in whom the were either a simple mastectomy with predominant histological abnormalities pectoral node biopsy or a modified radical were the presence of fibrosis and cyst mastectomy, axillary node histology was formation); available. In Edinburgh, where simple and Group 2-epitheliosis (17 patients) (lesions radical mastectomies were performed, it in which epitheliosis of a marked degree was possible to make a histological assesswas present); ment of the radical mastectomy group only Group 3-fibroadenomata (25 patients).
(68 patients), no axillary nodes being avail-able from those patients undergoing simple
As statistical analysis of urinary stermastectomy. oids with age revealed a log normal Urine collection and analysis.-Urine was distribution (Cameron et al., 1970) , aetiocollected from all patients pre-operatively; cholanolone levels have been expressed in Cardiff for 48 h and in Edinburgh for in logarithms to the base 10 of the con-24 h before operation.
The techniques used for estimation of centration (ag/24 h) aetiocholanolone were based on that described by Thomas and Bulbrook (1964) , and Thomas (1965) . Different modifications Scattergrams relating aetiocholanolone of these basic methods were introduced levels to age and menopausal status in separately in Cardiff (Cameron et al., 1970) the patients with early breast cancer, and Edinburgh (Sneddon, 1969) . These from Cardiff are shown in Fig. 1 and variations have led to minor differences from Edinburgh in Fig. 2 . These figures between centres with respect to extraction, also show the regression lines of aetiopurification and measurement of aetioc cholanolone, all of which are unlikely to colanopoesit age forpth preaffect quantitation. One major difference post-menopausal patient groups. The rebetween the methods employed in the gression coefficients for these lines do 2 centres, however, was the use of con-not differ significantly from zero. Age per jugated internal standards in Cardiff and se, therefore, has little effect on aetiofree steroid standards in Edinburgh in order cholanolone excretion in patients from to monitor manipulative losses. This is either city. There is, however, a signilikely to result in different absolute values ficant difference between the mean levels for aetiocholanolone in any given specimen of aetiocholanolone in the pre-and postof urine. The results from the 2 centres * p are therefore presented separately. Never-nau patnt s, ther betiong losb theless, any differences in aetiocholanolone stantial reduction in aetiocholanolone values between the centres ought to be excretion after the menopause. consistent, and the same relationship between Analysis of the control and benign aetiocholanolone and other parameters there-disease groups (restricted to 30 years fore would be expected in results from both and older) also revealed a similar pattern. Cardiff and Edinburgh.
Once subdivided into pre-and postmenopausal patients, age had no significant effect on the level of urinary RESULTS aetiocholanolone. The pre-menopausal The mean and standard deviation for patients, however, showed significantly the ages of the patient groups under increased levels compared with poststudy in Cardiff and Edinburgh is shown menopausal patients (Fig. 3, 4) . in Table I . The pre-menopausal, benign Information was available from a and control groups from Cardiff are number of patients under the age of considerably younger than the correspond-30 years-15 patients with benign disease ing cancer group. To achieve com-and 5 control patients from Cardiff. parability, only individuals aged 30 or These data are included in Fig. 5 and 6 , more have been compared in the subse-which show the relationship between quent tests of significance (see below).
the aetiocholanolone excretion for all of the pre-menopausal control patients and not apparent in the small number of for those with benign breast disease. women in the control group.
In the benign group, there is a gradual . . increase in aetiocholanolone levels up Variation with breast disease to the age of 30 cholanolone levels between benign, cancer undergoing radical mastectomy, from and control patients, whether preor whom histological examination of nodes post-menopausal, in women from either was possible. Cardiff or Edinburgh. The further sub-No consistent correlation was found division of the Edinburgh patients with between aetiocholanolone levels and any benign breast disease into those with of these factors of prognostic significance. fibroadenomata, fibroadenosis or epithe-Significant but diverging relationships liosis, revealed no differences between were, however, observed in Cardiff and these groups (Fig. 7) .
in the full Edinburgh series with regard to both tumour grade and round cell Correlatio with othinfiltration. No obvious reasons are ap-Correlation with other clinical and tumour parent for these paradoxical observations. parameters Size, malignancy grade and round cell DISCUSSION infiltration of the primary tumour, to-Using data obtained separately from gether with clinical palpability of lymph the 2 centres, it has been possible to nodes, were assessed in 191 patients from define the excretion of aetiocholanolone the 2 centres. Histological examination in control women and patients with of lymph nodes was performed on 120 benign and malignant breast disease, patients. The partial correlation coeffiwith respect to their age and menstrual cients of aetiocholanolone with each of status. By examining the data from the other variables are shown in I'able II. patients with early breast cancer, it has also been possible to relate these aetiocholanolone levels to other factors known seems, therefore, that the reduction in aetiocholanolone observed with increasing age is a result of the increasing proportion These coefficients reflect the association of post-menopausal women. This relabetween aetiocholanolone levels and each tionship is also observed in control of these variables, after mutual association patients and in those with benign breast with menopausal status and with each disease. of the other variables, has been taken The present study, using a large into account (Steel and Torrie, 1960) . number of patients, confirms the findings In the Edinburgh series, the full set of Wade et al. (1969) and Cameron et of partial correlation coefficients could al. (1970) that the mean urinary aetioonly be obtained for the 68 patients cholanolone levels of patients with early breast cancer are no different from those with either benign disease or in-patient controls. The observation that patients with epitheliosis (believed to be a premalignant condition) have normal aetiocholanolone levels does not support the suggestion that low aetiocholanolone levels may occur in women susceptible to breast cancer.
It has not been possible to demonstrate any consistent relationship between preoperative urinary aetiocholanolone and any single one of a series of clinical and morphological factors of known prognostic significance in women with early breast cancer. These observations, therefore, are at variance with the suggestion that aetiocholanolone is of major prognostic significance in early breast cancer (Hayward and Bulbrook, 1968) . In this respect, the time of the urine collection may be of importance. The data in the present study is based upon preoperative specimens whereas those in Bulbrook's study related to urine collected 10 days after mastectomy. It is now known that mastectomy, possibly via the stress of surgical procedures, influences both urinary and plasma levels of androgenic steroids (Hayward and Bulbrook, 1968; Wang et al., 1974) . Conversely, patients awaiting surgery are likely to suffer pre-operative stress and this may also contribute to differences in pre-and post-operative steroid excretion.
It should be noted, however, that this study shows one group of patients, i.e. the post-menopausal women, who are likely to have low urinary aetiocholanolone levels. It is therefore interesting that pre-menopausal women over 35 years with breast cancer have a better prognosis than those women who are post-menopausal (Hamilton et al., 1974) . We therefore emphasize the importance of menopausal status in early breast cancer and suggest that it should be taken into account when assessing the possible predictive value of urinary aetiocholanolone.
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